You are here

In Brief

QT Vascular clinical trial exceeds patient enrolment goal

QT VASCULAR said that the clinical trial for its Chocolate® Touch drug-coated balloon in Europe and New Zealand has "substantially exceeded" its patient enrolment goal for Q4 2014. The company expects to obtain CE

Market voices on:


Receive $80 Grab vouchers valid for use on all Grab services except GrabHitch and GrabShuttle when you subscribe to BT All-Digital at only $0.99*/month.

Find out more at

Powered by GET.comGetCom